Xylazole inhibits NO-cGMP pathway in fetal rat nerve cells

J Vet Sci. 2022 Jan;23(1):e16. doi: 10.4142/jvs.21188.

Abstract

Background: Xylazole (Xyl) is a veterinary anesthetic that is structurally and functionally similar to xylazine. However, the effects of Xyl in vitro remain unknown.

Objectives: This study aimed to investigate the anesthetic mechanism of Xyl using fetal rat nerve cells treated with Xyl.

Methods: Fetal rat nerve cells cultured for seven days were treated with 10, 20, 30, and 40 μg/ mL Xyl for 0, 5, 10, 15, 20, 25, 30, 45, 60, 90, and 120 min. Variations of amino acid neurotransmitters (AANTs), Nitric oxide-Cyclic GMP (NO-cGMP) signaling pathway, and ATPase were evaluated.

Results: Xyl decreased the levels of cGMP and NO in nerve cells. Furthermore, Xyl affected the AANT content and Na+-K+-ATPase and Ca2+-Mg2+-ATPase activity in nerve cells. These findings suggested that Xyl inhibited the NO-cGMP signaling pathway in nerve cells in vitro.

Conclusions: This study provided new evidence that the anesthetic and analgesic effects of Xyl are related to the inhibition of the NO-cGMP signaling pathway.

Keywords: Xylazole; anesthesia; cyclic GMP; gamma-aminobutyric acid; glutamic acid.

MeSH terms

  • Adenosine Triphosphatases
  • Animals
  • Animals, Newborn
  • Cells, Cultured
  • Cyclic GMP*
  • Neurons / drug effects*
  • Nitric Oxide*
  • Rats
  • Signal Transduction / drug effects*
  • Thiazoles / pharmacology*

Substances

  • Thiazoles
  • xylazole
  • Nitric Oxide
  • Adenosine Triphosphatases
  • Cyclic GMP